Phil Skolnick, Ph.D., D.Sc. (hon.)
Affiliations: | National Institutes of Health, Bethesda, MD |
Area:
anxiolytic drugs, GABA Receptors, glutamate, benzodiazepines, antidepressants, NMDA receptorGoogle:
"Phil Skolnick"Mean distance: 15.7 (cluster 7) | S | N | B | C | P |
Children
Sign in to add trainee| Esther Fride | post-doc | ||
| Richard Thomas Layer | post-doc | NIDDK | |
| Piotr Popik | post-doc | Institute of Pharmacology, Polish Academy of Sciences | |
| Ben Avi Weissman | post-doc | NIDDK, NIH | |
| Garry Wong | post-doc | NIH | |
| Todd D. McIntyre | post-doc | 1986-1990 | NIDDK, NIH |
| Ramon Trullas | post-doc | 1985-1991 | NIDDK |
| Ian A. Paul | post-doc | 1989-1993 | NIDDK |
| Li-Ming Zhou | post-doc | 1992-1994 | NIDDK, NIH |
| Yoshitatsu Sei | post-doc | 1988-1995 | NIDDK |
| Anthony S. Basile | post-doc | 1984-1996 | NIDDK, NIH |
| Norman Huang | post-doc | 1995-1997 | NIDDK, NIH |
| Pierre-Alain Boyer | post-doc | 1996-1997 | NIDDK |
| Hong Yu | research scientist | 1997-2001 | Eli Lilly & Co |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Skolnick P, Crystal R. (2019) Cannabinoid (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose. Journal of Neural Transmission (Vienna, Austria : 1996) |
| Krieter PA, Chiang CN, Gyaw S, et al. (2019) Pharmacokinetic Interaction of Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Krieter P, Gyaw S, Chiang CN, et al. (2019) Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose. Journal of Clinical Pharmacology |
| Skolnick P, Kos T, Czekaj J, et al. (2015) Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27: 228-34 |
| Popik P, Holuj M, Nikiforuk A, et al. (2015) 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38 |
| Kim SW, Fowler JS, Skolnick P, et al. (2014) Therapeutic doses of buspirone block D3 receptors in the living primate brain – CORRIGENDUM The International Journal of Neuropsychopharmacology. 17: 1354 |
| Bergman J, Roof RA, Furman CA, et al. (2013) Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 445-58 |
| Warnock KT, Yang AR, Yi HS, et al. (2012) Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology, Biochemistry, and Behavior. 103: 111-8 |
| Newman AH, Blaylock BL, Nader MA, et al. (2012) Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochemical Pharmacology. 84: 882-90 |
| Yang AR, Yi HS, Warnock KT, et al. (2012) Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research. 36: 863-73 |